Tazeen Ahmad

Stock Analyst at B of A Securities

(1.01)
# 2069
Out of 5,337 analysts
233
Total ratings
38.79%
Success rate
1.69%
Average return
55 Stocks
Name Action PT Current % Upside Ratings Updated
APLS Apellis Pharmaceutic...
Downgrades: Neutral
41 23
16.68 37.89% 7 May 9, 2025
PTCT PTC Therapeutics
Upgrades: Buy
55 68
46.77 45.39% 15 May 9, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
63 68
57.3 18.67% 8 Apr 10, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
302 325
267.48 21.5% 3 Mar 21, 2025
STRO Sutro Biopharma
Downgrades: Underperform
11 1
0.73 36.99% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 28
6.13 356.77% 2 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
73 70
40.38 73.35% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 40
3.15 1169.84% 4 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 28
13.99 100.14% 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
184 179
118.83 50.64% 3 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
26 22
6.92 217.92% 5 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
11.38 93.32% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6 3
1.39 115.83% 3 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
68 90
61.16 47.16% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
5.88 155.1% 5 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
11 6
6.39 -6.1% 14 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
175 191
157.39 21.35% 8 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 150
91.94 63.15% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 2
5.67 -64.73% 6 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
535 607
532.5 13.99% 3 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
166 213
35.76 495.64% 21 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
83 76
34.65 119.34% 6 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
26 22
17.17 28.13% 13 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
1.32 960.61% 2 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
1.75 471.43% 4 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
2 6
0.96 525% 2 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
6.99 114.59% 1 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3
n/a n/a 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 1
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
8 11
15.83 -30.51% 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
36 31
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
9.87 1.32% 6 Jul 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 2
1.8 11.11% 2 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
n/a n/a 3 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90 20
n/a n/a 2 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
0.92 552.17% 4 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
75 15
6.44 132.92% 3 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
390 60
36.98 62.25% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
23
n/a n/a 2 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
16
1.06 1409.43% 1 Nov 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Oct 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 20
n/a n/a 2 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13 5
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43
8.21 423.75% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
233 227
n/a n/a 4 Feb 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 3 Sep 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Apr 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
330 300
11.43 2524.67% 1 Nov 2, 2018